0001209191-20-030089.txt : 20200518
0001209191-20-030089.hdr.sgml : 20200518
20200518162807
ACCESSION NUMBER: 0001209191-20-030089
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200515
FILED AS OF DATE: 20200518
DATE AS OF CHANGE: 20200518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hagan Joseph P
CENTRAL INDEX KEY: 0001465278
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 20889922
MAIL ADDRESS:
STREET 1: 3344 N. TORREY PINES COURT, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 225
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 225
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-15
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001465278
Hagan Joseph P
C/O REGULUS THERAPEUTICS INC.
10628 SCIENCE CENTER DR., #225
SAN DIEGO
CA
92121
1
1
0
0
President and CEO
Common Stock
2020-05-15
4
S
0
4426
0.6267
D
226333
D
The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person on 11/12/2018. These sales are made pursuant to an existing 10b5-1 plan under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.
Christopher Aker, Attorney in Fact
2020-05-18